LCD characteristics identified

Article

A paper in Retina has announced the identification of the morphologic characteristics of early onset large colloid drusen (LCD) using SD-OCT.

A paper in Retina has announced the identification of the morphologic characteristics of early onset large colloid drusen using SD-OCT.

Dr Benjamin Guigui et al., Creteil University Eye Clinic, Faculte de Medecine Henri Mondor, Creteil, France, performed a complete ophthalmic examination using SD-OCT in 22 eyes of 11 consecutive patients.

Mean visual acuity was 20/25 and the mean patient age was 35 years old at diagnosis. SD-OCT revealed multiple dome-shaped retinal pigment epithelium detachments corresponding to the drusen. The mean height of the drusen was 199 μm and mean width was 419 μm.

Indocyanine green angiography hypofluorescent LCD were bigger and more reflective on SD-OCT. The characteristics of the retina overlying LCD were wavy and thinned overall.

In 73% of the eyes there was prominent diffuse hyperreflective haze in the Henle fibre layer over drusen. There were no cases of geographic atrophy or choroidal neovascularization.

The SD-OCT features provide an insight on the ultrastructure of LCD. Further studies could be planned for the follow-up and histologic evaluation in order to confirm the clinical significance of LCD.

For more information please read the journal abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.